Sakar Healthcare Ltd.

₹889.8

-62 (-6.5%)

SAKAR Share Price

Pharmaceuticals & Biotechnology

As on October 23, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 1,979.8 Cr

P/E Ratio64.94

Dividend YieldN/A

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	926.26	Bearish
10-DMA	958.62	Bearish
20-DMA	1,015.4	Bearish
50-DMA	1,011.04	Bearish
100-DMA	928.12	Bearish
200-DMA	731.05	Bullish

Historical Performance

1 Year

144.8%

3 Years

153.9%

5 Years

483.7%

10 Years

1604.6%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Net Sales	2,517	1,776	1,534	1,334	1,282
Total Expenditure	1,824	1,279	1,150	1,001	989
Other Income	23	13	32	47	22
Operating Profit	716	510	416	379	315
Interest	83	86	76	60	29
Depreciation	236	209	181	150	97
Profit Before Tax	398	215	159	170	189
Consolidated Net Profit	305	175	117	128	152
Adjusted EPS	14	8	5	7	9

Compounded Sales Growth

10 Years:24.9

5 Years:21.6

3 Years:13.5

TTM:7.2

Compounded Profit Growth

10 Years:25.9

5 Years:23.3

3 Years:19

TTM:11.7

Stock Price CAGR

10 Years:32.8

5 Years:42.3

3 Years:36.4

TTM:149.9

Return on Equity

10 Years:N/A

5 Years:8.9

3 Years:5.4

last year:13.7

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Share Capital	222	219	217	190	171
Total Reserves	3,022	2,606	2,358	1,543	1,103
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	470	666	673	1,085	935
Other Current Liabilities	254	194	163	136	86
Short Term Borrowings	240	214	139	130	45
Total Liabilities	4,810	4,153	3,887	3,363	2,678
Capital Work in Progress	40	167	3	65	12
Long Term Loans & Advances	101	9	24	73	119
Currents Investments	---	---	---	34	71
Short Term Loans and Advances	193	138	216	145	143
Total Current Assets	1,405	887	716	559	500
Total Assets	4,810	4,153	3,887	3,363	2,678
Adjusted Book Value	146	129	118	91	74

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 64.94, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a strong 3-year price CAGR of 38.1%, indicating sustained price appreciation.
The stock carries a low beta of 0.7, suggesting lower volatility than the broader market.
In the last financial year, the company reported an EBITDA of ₹716 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹2517 million, suggesting a mid-sized operation.

Investment Calculator

Investment Amount:₹

Investment Amount: ₹ 1000000

Current Value: ₹ 2496983.3

No. of Shares: 2806 (Approx)

Performance:149.7%

1496983.3

NIFTY Performance: -12.4%

1 day Top Gainers